Department of Vascular Surgery, University Medical Center Utrecht, The Netherlands.
J Endovasc Ther. 2012 Apr;19(2):291-302. doi: 10.1583/11-3766R.1.
At present, no widely accepted surgical options exist for treating chronic deep venous insufficiency (CDVI). Experimental efforts to improve catheter-based management for CDVI have shown disappointing results, hindering application of these techniques in the clinical arena. A review of the literature focusing on technical aspects of valve stent design was conducted. Eight experimental studies were scrutinized to derive data on (1) stent design and configuration; (2) valve design, composition, and configuration; (3) delivery system; (4) functional outcome; and (5) histology to provide a basis for the design of a new prosthetic venous valve. The analysis of available experimental data found that all prosthetic valve designs currently under development/testing rely on some type of a stent to act as a carrier or frame for valve attachment. Most valve models reviewed were for the most part implanted safely and accurately, with good short-term patency and competency. The most commonly reported adverse event was thrombosis, which limited durability. It is assumed that valve configuration determines long-term results after repair. Hence, the newly proposed valve design consisted of 2 stent rings without barbs to fix the valve in the host vein. Because a little reflux might actually benefit the patency of the valve, the valve cusp in the new design forms a billowing "sail" that does not completely open or close, which also prevents the valve cusp from sticking to the wall. This technology remains of great interest to the interventionist and all physicians who are involved in the care for patients with advanced chronic venous disease. Valve design remains a challenge, but promising new valve substitutes such as the one outlined here are under evaluation.
目前,尚无被广泛接受的治疗慢性深静脉功能不全(CDVI)的手术方法。改善 CDVI 经导管治疗的实验性努力并未取得令人满意的结果,从而阻碍了这些技术在临床领域的应用。本文对重点关注瓣膜支架设计技术方面的文献进行了综述。仔细研究了 8 项实验研究,以获取以下数据:(1)支架设计和构型;(2)瓣膜设计、组成和构型;(3)输送系统;(4)功能结果;(5)组织学,为设计新型人造静脉瓣膜提供依据。对现有实验数据的分析发现,目前正在开发/测试的所有人造瓣膜设计都依赖于某种类型的支架作为瓣膜附着的载体或框架。大多数审查的瓣膜模型在很大程度上安全且准确地植入,具有良好的短期通畅性和功能。最常报告的不良事件是血栓形成,这限制了耐用性。据推测,瓣膜构型决定了修复后的长期结果。因此,新提出的瓣膜设计由 2 个无倒钩的支架环组成,以将瓣膜固定在宿主静脉中。由于少量反流实际上可能有益于瓣膜通畅性,因此新设计中的瓣膜瓣形成了一个起伏的“帆”,不会完全打开或关闭,这也防止了瓣膜瓣贴壁。这项技术仍然引起介入治疗医生和所有参与治疗晚期慢性静脉疾病患者的医生的极大兴趣。瓣膜设计仍然是一个挑战,但像这里概述的那样有前途的新型瓣膜替代品正在评估中。